257 related articles for article (PubMed ID: 32764436)
1. aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
Lähteenmäki H; Umeizudike KA; Heikkinen AM; Räisänen IT; Rathnayake N; Johannsen G; Tervahartiala T; Nwhator SO; Sorsa T
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32764436
[TBL] [Abstract][Full Text] [Related]
2. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
[TBL] [Abstract][Full Text] [Related]
3. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of aMMP-8 and azurocidin in peri-implant sulcular fluid as biomarkers of peri-implant health or disease.
Xanthopoulou V; Räisänen IT; Sorsa T; Tortopidis D; Sakellari D
Clin Exp Dent Res; 2024 Jun; 10(3):e883. PubMed ID: 38853451
[TBL] [Abstract][Full Text] [Related]
5. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
[TBL] [Abstract][Full Text] [Related]
6. aMMP-8 point-of-care - diagnostic methods and treatment modalities in periodontitis and peri-implantitis.
Lähteenmäki H; Pätilä T; Pärnänen CP; Räisänen I; Tervahartiala T; Gupta S; Sorsa T
Expert Opin Ther Targets; 2023; 27(7):627-637. PubMed ID: 37522314
[TBL] [Abstract][Full Text] [Related]
7. Host-Modulation Therapy and Chair-Side Diagnostics in the Treatment of Peri-Implantitis.
Sorsa T; Bacigalupo J; Könönen M; Pärnänen P; Räisänen IT
Biosensors (Basel); 2020 Apr; 10(5):. PubMed ID: 32344881
[TBL] [Abstract][Full Text] [Related]
8. Active MMP-8 as a Biomarker of Peri-implant Health or Disease.
Xanthopoulou V; Räisänen I; Sorsa T; Sakellari D
Eur J Dent; 2023 Jul; 17(3):924-928. PubMed ID: 36063841
[TBL] [Abstract][Full Text] [Related]
9. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
[TBL] [Abstract][Full Text] [Related]
10. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases.
Alassiri S; Parnanen P; Rathnayake N; Johannsen G; Heikkinen AM; Lazzara R; van der Schoor P; van der Schoor JG; Tervahartiala T; Gieselmann D; Sorsa T
Dis Markers; 2018; 2018():1306396. PubMed ID: 30154936
[TBL] [Abstract][Full Text] [Related]
11. Salivary Diagnostics-Point-of-Care diagnostics of MMP-8 in dentistry and medicine.
Rathnayake N; Gieselmann DR; Heikkinen AM; Tervahartiala T; Sorsa T
Diagnostics (Basel); 2017 Jan; 7(1):. PubMed ID: 28117682
[TBL] [Abstract][Full Text] [Related]
12. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
[TBL] [Abstract][Full Text] [Related]
13. Peri-Implant Sulcus Fluid (PISF) Matrix Metalloproteinase (MMP) -8 Levels in Peri-Implantitis.
Thierbach R; Maier K; Sorsa T; Mäntylä P
J Clin Diagn Res; 2016 May; 10(5):ZC34-8. PubMed ID: 27437357
[TBL] [Abstract][Full Text] [Related]
14. Peri-implantitis in partially edentulous patients: association with inadequate plaque control.
Serino G; Ström C
Clin Oral Implants Res; 2009 Feb; 20(2):169-74. PubMed ID: 19077152
[TBL] [Abstract][Full Text] [Related]
15. Microbiological and aMMP-8 findings depending on peri-implant disease in patients undergoing supportive implant therapy.
Ziebolz D; Schmalz G; Gollasch D; Eickholz P; Rinke S
Diagn Microbiol Infect Dis; 2017 May; 88(1):47-52. PubMed ID: 28274501
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis.
Keskin M; Rintamarttunen J; Gülçiçek E; Räisänen IT; Gupta S; Tervahartiala T; Pätilä T; Sorsa T
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900047
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study.
Xu L; Yu Z; Lee HM; Wolff MS; Golub LM; Sorsa T; Kuula H
Acta Odontol Scand; 2008 Aug; 66(4):219-24. PubMed ID: 18615324
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis.
Aleksandrowicz P; Żelechowska P; Agier J; Starska K; Kędzierski K; Wysokińska-Miszczuk J; Brzezińska-Błaszczyk E
Mediators Inflamm; 2017; 2017():4920847. PubMed ID: 28757684
[TBL] [Abstract][Full Text] [Related]
19. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
Kivelä-Rajamäki M; Maisi P; Srinivas R; Tervahartiala T; Teronen O; Husa V; Salo T; Sorsa T
J Periodontal Res; 2003 Dec; 38(6):583-90. PubMed ID: 14632921
[TBL] [Abstract][Full Text] [Related]
20. Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era.
Räisänen IT; Umeizudike KA; Pärnänen P; Heikkilä P; Tervahartiala T; Nwhator SO; Grigoriadis A; Sakellari D; Sorsa T
Med Hypotheses; 2020 Nov; 144():110276. PubMed ID: 33254580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
